Zhejiang Tailin BioEngineering Co.,Ltd (ZHEJIANG TAILIN BIOENGINEERING ) Aktie

Zhejiang Tailin BioEngineering Co.,Ltd engages in the research and development, production, and sale of microbial detection, contamination control, process analysis, and inhibition protection in the life sciences field in China and internationally. The company primarily offers aseptic production and contamination control equipment, microbial testing products, and organic matter analysis technology products. It also provides pharma processing, such as pharma isolators, high-precision filling and dispensing, sterile transfer; cell and gene therapy; radiopharma; laboratory animal; leak test systems; biodecontamination, including VH2O2 sterilization system and dry fogging system; sterilization monitoring and validation; microbiological testing, comprising sterility and microbial limit test system and pretreatment instruments; and water quality, consisting of microbial monitoring and aquatic organism detection system, total organic carbon (TOC) analysis, enzyme substrate method, and automatic detection system for cryptosporidium and giardia. In addition, the company offers filtration membranes, such as flat and blotting membranes, IVD series, membrane filters and dispensers; and analytical instruments, including filter integrity testing, container closure integrity testers (CCIT), water activity meters, and biodegradation analysis systems. Its products are used in biopharmaceuticals, medical and health care, laboratory animal research, food safety, disease control, water quality monitoring, and environmental protection. The company was formerly known as Hangzhou Tailin Biotechnology Equipment Co., Ltd. and changed its name to Zhejiang Tailin BioEngineering Co.,Ltd in April 2015. Zhejiang Tailin BioEngineering Co.,Ltd was founded in 1993 and is based in Hangzhou, China.